Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11427581
JAK inhibitor and use thereof
granted -
US 11420965
Pyrimidine compound as JAK kinase inhibitor
granted -
US 11420936
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
granted -
US 11414379
SPAK kinase inhibitors as neuroprotective agents
granted -
US 11414489
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor
granted -
US 11407998
Twist signaling inhibitor compositions and methods of using the same
granted -
US 11406713
Xanthine oxidase inhibitor formulations
granted -
US 11407723
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11407712
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
granted -
US 11407736
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11401286
Heteroaryl inhibitors of PDE4
granted -
US 11401246
Triazole glycolate oxidase inhibitors
granted -
US 11390631
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11389433
BRD4 inhibitor treatment of IgE-mediated diseases
granted -
US 11390646
Structure-based peptide inhibitors of α-synuclein aggregation
granted -
US 11384065
Heterocyclic compound as CSF-1R inhibitor and use thereof
granted -
US 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11384076
Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors
granted -
US 11384055
Glycolate oxidase inhibitors for the treatment of disease
granted -
US 11377428
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11377444
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors
granted -
US 11376247
Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
granted -
US 11377469
CD73 inhibitors
granted -
US 11370774
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted